Skip Navigation


BJA Advance Access originally published online on October 21, 2005
British Journal of Anaesthesia 2005 95(6):773-775; doi:10.1093/bja/aei263
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/6/773    most recent
aei263v1
Right arrow E-Letters: Submit a response to the article
Right arrow E-letters: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ho, A. M.-H.
Right arrow Articles by Karmakar, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ho, A. M.-H.
Right arrow Articles by Karmakar, M. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

CASE REPORT

Central apnoea after balanced general anaesthesia that included dexmedetomidine

A. M.-H. Ho*, S. Chen and M. K. Karmakar

Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, PRC

* Corresponding author. E-mail: hoamh{at}hotmail.com

Dexmedetomidine is an {alpha}2-adrenoreceptor agonist that, in spite of its potent sedative, amnesic, and analgesic properties, has minimal respiratory depressant effect. Even at doses adequate for general anaesthesia, it does not cause central apnoea. Thus, it has been claimed that ‘combining {alpha}2-agonists with opiate narcotics or non-steroidal anti-inflammatory drugs can enhance the analgesic efficacy without increasing the respiratory depressant effect of the latter’ and ‘the combination of {alpha}2-adrenoceptor agonists with opioids does not lead to further ventilatory depression’. We present a case of central apnoea after general anaesthesia that included opioids and dexmedetomidine, and remind the readers that in susceptible patients, dexmedetomidine may cause life-threatening respiratory depression through potentiation of co-administered central nervous system depressants.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
S. A. Chung, H. Yuan, and F. Chung
A Systemic Review of Obstructive Sleep Apnea and Its Implications for Anesthesiologists
Anesth. Analg., November 1, 2008; 107(5): 1543 - 1563.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
Y. Y. S. Lee, S. M. Wong, and C. T. Hung
Dexmedetomidine infusion as a supplement to isoflurane anaesthesia for vitreoretinal surgery
Br. J. Anaesth., April 1, 2007; 98(4): 477 - 483.
[Abstract] [Full Text] [PDF]

E-letters:

Read all E-letters

Balanced general anaesthesia including dexmedetomidine
Olumuyiwa A Bamgbade
British Journal of Anaesthesia, 2 Dec 2005 [Full text]
Mixed opioid use the cause?
Alfred P J Lake, et al.
British Journal of Anaesthesia, 10 Feb 2006 [Full text]

Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.